Amarin to Stack up board with Pacira CEO
This article was originally published in Scrip
Amarin, a biopharmaceutical company focused on cardiovascular therapeutics, has appointed David Stack to its board of directors. Mr Stack currently serves as president and CEO of Pacira Pharmaceuticals, and is also a managing director at MPM Capital and founding partner of Stack Pharmaceuticals. He was previously president and CEO of The Medicines Company.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.